This publication is intended as an educational resource for healthcare professionals. It discusses the risks of herpes zoster infection and the mechanisms of immune dysfunction in immunocompromised adults, as well as management of active infection in this population. The last part of the publication focuses on prevention of herpes zoster through vaccination, with specific recommendations for immunocompromised adults, as well as a summary of clinical trial outcomes in these individuals.
Please login below to download this issue (PDF)